Money moves in silence. Download 2025 State of Venture Report: a data-driven analysis of active funds, unicorn, and family offices
About usSign in
Status
ACTIVE
Global HQ
Saint Louis, United States
Countries of investment
  • USA
Investment stages
  • Pre-Seed
  • Seed
  • Series A
  • Series B
Industries
    About
    Rivervest is a prominent venture capital firm that specializes in creating and funding life science companies, particularly in the biopharma and medical device sectors, to tackle significant unmet medical needs.
    Min check size
    $1M
    Max check size
    $10M
    Fund size
    NPS

    Investment Thesis

    Improving the lives of patients, supporting entrepreneurs, and earning the trust of investors through science, strategy, and innovation.
    Lead investor
    Co Invest
    Number of exits
    Preferred contact method

    Manager's Experience

    Backed by extensive experience in venture capital, the fund manager has successfully navigated multiple investment stages, focusing on early to growth-stage opportunities. With a strong emphasis on technology and healthcare sectors across North America and Europe, they have executed over 50 deals, showcasing a data-driven and thematic investment approach. Notable exits underscore their operator-first strategy, demonstrating an ability to leverage deep operational insights to maximize returns. Their track record reflects a commitment to identifying transformative companies poised for significant market impact.

    RiverVest Contacts Information

    Primary contact

    Secondary contact

    Team

    Tom Melzer

    Sara Mesiano

    Regen Biologics

    Niall O芒聙聶Donnell

    Marilyn Slavich

    John Mckearn

    Jay Schmelter

    Gordon Foulkes

    Derek Rapp

    Dennis Wahr

    Fund number
    Vintage Year
    Net Internal Rate of Return
    Investment Multiple
    Capital Allocation
    Management Fee
    Carried Interest
    AUM
    Follow-on Investments
    Graduation Rate
    Write-Off Ratio
    Last profile update timestamp